SCHEMBL12420232

SCHEMBL12420232

O=C1c2ccc(B(O)O)cc2C(=O)N1CCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ RAB9A P51151 3/20 0.51
▸ GAA P10253 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ CA1 P00915 3/20 0.51
▸ CA4 P22748 3/20 0.51
▸ CA12 O43570 1/20 0.51
▸ CA7 P43166 1/20 0.51
▸ GRM5 P41594 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CYP1B1 Q16678 1/20 0.48
▸ CA2 P00918 3/20 0.47
▸ CA9 Q16790 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12420229 0.85 KMT2A (0.62) CASP3ALDH1A1MAPTSMN1; SMN2CA1
SCHEMBL1142116 0.79 CASP3 (0.86) CASP3ALDH1A1MAPTRAB9AGAA
SCHEMBL29724090 0.79 CASP3 (0.86) CASP3ALDH1A1MAPTRAB9AGAA
SCHEMBL10661191 0.78 CASP3 (0.62) CASP3ALDH1A1MAPTRAB9AGAA
SCHEMBL10586404 0.78 ALDH1A1 (0.68) CASP3ALDH1A1MAPTRAB9AGAA
SCHEMBL8040297 0.78 PARK7 (0.68) CASP3ALDH1A1MAPTRAB9AGAA
SCHEMBL822573 0.76 ALDH1A1 (0.75) CASP3ALDH1A1MAPTRAB9AGAA
SCHEMBL2627975 0.76 PARP1 (0.47) ALDH1A1MAPTRAB9AGAAKDM4E
SCHEMBL12420227 0.75 KDM4E (0.48) ALDH1A1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL16832060 0.75 POLB (0.57) ALDH1A1RAB9AGAAKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 CASP3 1792/4885ALDH1A1 354/4885MAPT 3395/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 CASP3 1792/4885ALDH1A1 354/4885MAPT 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback